‘discovery’
Profiling chromatin accessibility and DNA methylation—simultaneously
Feb. 1, 2022—Research led by Emily Hodges, assistant professor of biochemistry, first-author Lindsey Guerin, a graduate student in the Hodges lab, and Kelly Barnett, a recent graduate of the Hodges lab, developed and tested a new method called ATAC-Me, which profiles multiple epigenetic features, including DNA methylation, simultaneously from a single DNA source. Hodges’s recent work using...
Profiling chromatin accessibility and DNA methylation—simultaneously
Feb. 1, 2022—By Aaron Conley Research led by Emily Hodges, assistant professor of biochemistry, first-author Lindsey Guerin, a graduate student in the Hodges lab, and Kelly Barnett, a recent graduate of the Hodges lab, developed and tested a new method called ATAC-Me, which profiles multiple epigenetic features, including DNA methylation, simultaneously from a single DNA source. Hodges’s...
Flipping the script on flippases
Dec. 6, 2021—Todd Graham, Stevenson Chair of Biological Sciences and professor of cell and developmental biology, and external collaborators recently published a paper describing the structure of a yeast “flippase” called Neo1. The research was led by three co-first authors: Bhawik Jain, a postdoc from the Graham lab, Lin Bai from Peking University, and Qinglong You from...
Calipari named Dean’s Faculty Fellow
Dec. 1, 2021—Erin Calipari, assistant professor of pharmacology and member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early stages of their career. The award targets...
Flipping the script on flippases
Nov. 30, 2021—By Wendy Bindeman Todd Graham, Stevenson Chair of Biological Sciences and professor of cell and developmental biology, and external collaborators recently published a paper describing the structure of a yeast “flippase” called Neo1. The research was led by three co-first authors: Bhawik Jain, a postdoc from the Graham lab, Lin Bai from Peking University, and...
Calipari named Dean’s Faculty Fellow
Nov. 29, 2021—By Aaron Conley Erin Calipari, assistant professor of pharmacology and member of the Vanderbilt Center for Addiction Research, has been named a Dean’s Faculty Fellow of the School of Medicine Basic Sciences. The Dean’s Faculty Fellows program, started in 2020, is designed to recognize the efforts of faculty in the early stages of their career....
Burkewitz awarded $100,000 to conduct longevity research at the cellular level
Nov. 22, 2021—Kristopher Burkewitz, assistant professor of cell and developmental biology, has been awarded $100,000 from the American Federation for Aging Research and the Glenn Foundation for Medical Research to research the biological aging process. Burkewitz was one of 10 recipients nationally of this early-career award. Burkewitz’s project will work to understand the sequence of events in...
Mosquitoes have a mutual symbiotic relationship with malaria-causing pathogen
Nov. 19, 2021—Cornelius Vanderbilt Professor of Biological Sciences Laurence J. Zwiebel is part of a team of researchers at Vanderbilt and the Johns Hopkins Malaria Research Institute who are working to understand how Plasmodium falciparum—the pathogen that causes malaria in humans—affects the mosquitoes that spread the disease. The research was spearheaded by Ann Carr, a current visiting...
Professor makes Vanderbilt-discovered cancer targeting molecule freely available to researchers through collaboration with Boehringer Ingelheim
Nov. 15, 2021—Stephen Fesik, Orrin H. Ingram II Chair in Cancer Research, has conducted pioneering research on some of the most difficult drug discovery targets in cancer research. As a result of his lab’s discoveries, molecule-specific data has been made freely available for download to cancer researchers on the opensource platform opnMe.com, which is an initiative being driven...
New target identified for rapid antidepressant drugs
Nov. 10, 2021—THE IDEA Vanderbilt researchers found that ketamine’s rapid antidepressant action is due to specific synaptic effects. This represents a new target for drug development that could fill a major gap in care for depression. Ege Kavalali (Vanderbilt University) Lisa Monteggia (John Russell/Vanderbilt University) The research was led by Lisa Monteggia, professor of pharmacology and director...